Mark R. Kelley, PhD, to present "Exploiting the Ref-1/APE 1 signaling node for targeted cancer therapy: From bench to first-in-class clinical trial."
Dr. Kelley is a Professor and Chair at the Indiana University School of Medicine.
Join Zoom Meeting
Wednesday, May 8 at 3:30pm to 4:30pm
No recent activity
